{"id":"W4386277272","doi":"10.1016/s2152-2650(23)00909-6","title":"POSTER: CT-356 Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3, a Phase III Randomized Controlled Trial (RCT)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Randomized controlled trial; Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Oncology; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001418454,0.001301828,0.00233218,0.0003028209,0.0004536129,0.001173117,0.0007381235,0.001708736,0.0225125],"category_scores_gemma":[0.001936013,0.0005738654,0.002827711,0.0003194191,0.000756568,0.0009781558,0.0004342594,0.004728966,0.002098879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007301018,"about_ca_system_score_gemma":0.0008922521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001260472,"about_ca_topic_score_gemma":0.002395708,"domain_scores_codex":[0.9994755,0.0002624582,0.00003820789,0.0001029907,0.00003556026,0.00008528477],"domain_scores_gemma":[0.9991404,0.0003151278,0.0001983022,0.00004594929,0.00005056843,0.0002496096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9698536,0.002392736,0.0003972678,0.001702057,0.002578298,0.00002230716,0.00004038373,0.0002704599,0.001294077,0.000142087,0.002316207,0.01899045],"study_design_scores_gemma":[0.9568986,0.03689251,0.001674637,0.0001448206,0.002145645,0.00002286144,0.00002481697,0.0002039486,0.000373259,0.000163658,0.001440075,0.00001506722],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9374998,0.03154609,0.00132656,0.005115888,0.003727985,0.004760328,0.00501644,0.000446783,0.0105603],"genre_scores_gemma":[0.974427,0.007962747,0.001722194,0.003546812,0.001067852,0.002238726,0.001638753,0.00004694446,0.00734892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0225125,"threshold_uncertainty_score":0.07531178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03215105575400953,"score_gpt":0.3358029235009634,"score_spread":0.3036518677469539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}